Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Fulcrum Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- −5 vs. Q1 2022
- Shares held
- 40.0M
- +533.6K (+1.4%) vs. Q1 2022
- Total value
- $196.6M
- −$733.2M (−78.9%) vs. Q1 2022
- New holders
- 20
- 40 more added
- Sold out
- 25
- 22 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 6,127,231 | $30.0M | 0.00% | +30,753+0.5% | Added |
| International Biotechnology Trust PLC | 949 | – | – | −81,792−98.9% | Reduced |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −236,991−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −229,509−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −212,961−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −188,651−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −136,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −116,622−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −87,100−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −66,120−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −48,921−100.0% | Sold out |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 0 | $0 | 0.00% | −17,797−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −15,001−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −9,496−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −9,351−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −15,785−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −5,277−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,187−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,783−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,469−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −790−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |